Updates on Biotech Stocks Celladon Corporation ( CLDN )Top line data due out on Systolic Heart Failure. They have FDA Fast Track and Breakthrough Therapy Designations. We think this stock could bethenext $billion dollar blockbuster see $80.
The Fly On the Wall
Breaking News Feed 3/13
Celladon Corporation ( CLDN )
Back To BoardPrevious topic Next topic
Celladon Shares May Have Upside to $70
The developer of gene therapy for heart failure to announce pivotal trial results
Received Breakthrough Therapy for upcoming Pivotal Trial
November 12, 2014
We received Breakthrough Therapy designation for CUPID2 and the use of MYDICAR from the FDA inApril of this year," said Krisztina Zsebo, Ph.D., Chief Executive Officer of Celladon.
wasn't aware there was 5 car-ts thank you
Sentiment: Strong Buy
looks good guys
Mad Money Remix 2/22/15
Investor Business Daily
Mutual Funds Are Buying Up This Cybersecurity Stock
BY ALISSA WILLIAMS, INVESTOR'S BUSINESS DAILY
Its high Accumulation/Distribution Rating can be attributed, in part, to its strong industry group, withtop-rated CyberArk Software
Cyber Security Market Forecast 2014-2015
LONDON/PRNewswire/ -- With attackers able to strike from anywhere and inflict damage on a significant(but often unnoticed) scale, the threat has never been greater. As a consequence, visigain has asessed that the value of the global Cyber Security market in 2014 will reach $76.68bn and will continue to grow
Per research firm Gartner, worldwide spending on IT security in 2014 was about $70 billion.